Certified by Founder
Lodge
Indomo
start up
United States
- Greater Boston
- 04/11/2025
- Unknown
- $25,000,000
A clinical-stage therapeutics company, Indomo pairs proven medicines with novel delivery systems to create fast-acting, self-administered treatments for inflammatory skin conditions. Its debut investigational product, the ClearPen, combines an established, trusted therapeutic with a novel microneedle device for at-home acne treatment.
- Industry Biotechnology Research
- Website https://www.indomotx.com/
- LinkedIn https://www.linkedin.com/company/indomotx/
Tribe Stays | $2,800,000 | (Nov 18, 2025)
No Barrier Medical Translation | $2,700,000 | (Nov 18, 2025)
PowerLattice | $25,000,000 | (Nov 18, 2025)
Shipday | $7,000,000 | (Nov 18, 2025)
Muse Software | $4,500,000 | (Nov 18, 2025)
Artios | $115,000,000 | (Nov 18, 2025)
Scripta Therapeutics | $12,000,000 | (Nov 18, 2025)
Self Labs | $9,000,000 | (Nov 18, 2025)
Obello | $8,500,000 | (Nov 18, 2025)
AlertD | $3,000,000 | (Nov 18, 2025)
Skeletalis, Inc. | $8,000,000 | (Nov 18, 2025)
Span(US) | $25,000,000 | (Nov 18, 2025)